Ergothioneine vs Livagen
A side-by-side research comparison of Ergothioneine and Livagen across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Ergothioneine | Livagen |
|---|---|---|
| Full name | L-Ergothioneine | Livagen (Lys-Glu-Asp-Ala Liver/Lymphocyte Bioregulator) |
| Category | Detox & Antioxidant | Detox & Antioxidant |
| Status | OTC supplement | Research compound (peptide bioregulator) |
| Mechanism | Accumulates via the OCTN1 transporter in mitochondria and other high-stress cellular compartments, where it scavenges reactive oxygen species, chelates metals, protects DNA and mitochondria, and preserves other antioxidants. | As a signal peptide (Lys-Glu-Asp-Ala), it is proposed to decondense chromatin (heterochromatin) in lymphocytes and regulate gene expression in hepatic tissue, supporting liver function and cellular activity. |
| Molecular weight | 229.30 Da | ~460 Da |
| Half-life | Very long (weeks; retained in tissue) | Short (peptide) |
| Bioavailability | Good oral via OCTN1 transporter | Oral (encapsulated) or subcutaneous |
| Typical dose | 5-25 mg per day | ~1-2 capsules/day or short injectable courses |
| Frequency | Once daily | Once daily |
| Route | Oral capsule | Oral capsule or subcutaneous |
Ergothioneine reported benefits
- Potent cellular and mitochondrial antioxidant
- Long tissue retention
- DNA and lipid protection
- Neuroprotective potential
- Associated with lower age-related disease risk
- Anti-inflammatory
Livagen reported benefits
- Liver function support
- Lymphocyte chromatin activation (proposed)
- Detox/antioxidant support
- Short course-based protocol
Related comparisons
Research and educational reference only. Not medical advice.